1. 2207: A Phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer. Issue 1 (10th May 2018) Authors: Ezra Shabason, Jacob; Chen, Jerry; Apisarnthanarax, Smith; Damjanov, Nevena; Giantonio, Bruce; Loaiza-Bonilla, Arturo; O'Dwyer, Peter; O'Hara, Mark; Reiss, Kim; Teitelbaum, Ursina; Wissel, Paul; Drebin, Jeffery; Vollmer, Charles; Kochman, Michael; Mick, Rosemarie; Vergara, Norge; Jhala, Nirag; Be... Journal: Journal of clinical and translational science Issue: Volume 1:Issue 1(2017) Page Start: 32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case‐matched study of toxicity outcomes after proton therapy and intensity‐modulated radiation therapy for prostate cancer. Issue 7 (25th November 2014) Authors: Fang, Penny; Mick, Rosemarie; Deville, Curtiland; Both, Stefan; Bekelman, Justin E.; Christodouleas, John P.; Guzzo, Thomas J.; Tochner, Zelig; Hahn, Stephen M.; Vapiwala, Neha Journal: Cancer Issue: Volume 121:Issue 7(2015) Page Start: 1118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours. Issue 10 (13th November 2018) Authors: Maity, Amit; Mick, Rosemarie; Huang, Alexander; George, Sangeeth; Farwell, Michael; Lukens, John; Berman, Abigail; Mitchell, Tara; Bauml, Josh; Schuchter, Lynn; O'Hara, Mark; Lin, Lilie; Demichele, Angela; Christodouleas, John; Haas, Naomi; Patsch, Dana; Hahn, Stephen; Minn, Andy; Wherry, E.; Von... Journal: British journal of cancer Issue: Volume 119:Issue 10(2018) Page Start: 1200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes. (1st January 2021) Authors: Maity, Amit; Mick, Rosemarie; Rengan, Ramesh; Mitchell, Tara C.; Amaravadi, Ravi K.; Schuchter, Lynn M.; Pryma, Daniel A.; Patsch, Dana M.; Maity, Alisha P.; Minn, Andy J.; Vonderheide, Robert H.; Lukens, John N. Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer. (2nd September 2017) Authors: Lowenfeld, Lea; Zaheer, Salman; Oechsle, Crystal; Fracol, Megan; Datta, Jashodeep; Xu, Shuwen; Fitzpatrick, Elizabeth; Roses, Robert E.; Fisher, Carla S.; McDonald, Elizabeth S.; Zhang, Paul J.; DeMichele, Angela; Mick, Rosemarie; Koski, Gary K.; Czerniecki, Brian J. Journal: Oncoimmunology Issue: Volume 6:Number 9(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer. (7th November 2013) Authors: Kandalaft, Lana E; Chiang, Cheryl; Zsiros, Emese; Tanyi, Janos; Powell, Daniel; Mick, Rosemarie; Coukos, George Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana. Issue 12 (30th December 2019) Authors: Grover, Surbhi; Zetola, Nicola; Ramogola-Masire, Doreen; Bvochora-Nsingo, Memory; Schnader, Allison F; Mick, Rosemarie; Gabaitiri, Lesego; Matlhagela, Keikantse; Shen, Hao; Chiyapo, Sebathu; Balang, Dawn; Phaladze, Nthabiseng; Nkomazana, Oathokwa; Friedman, Harvey; Jemmott, John; Chilisa, Bagele;... Journal: BMJ open Issue: Volume 9:Issue 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study. Issue 1 (January 2021) Authors: O'Hara, Mark H; O'Reilly, Eileen M; Varadhachary, Gauri; Wolff, Robert A; Wainberg, Zev A; Ko, Andrew H; Fisher, George; Rahma, Osama; Lyman, Jaclyn P; Cabanski, Christopher R; Mick, Rosemarie; Gherardini, Pier Federico; Kitch, Lacey J; Xu, Jingying; Samuel, Theresa; Karakunnel, Joyson; Fairchild... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3. Issue 1 (December 2015) Authors: Yang, Rachel; Mick, Rosemarie; Lee, Kathreen; Graves, Holly; Nathanson, Katherine; Domchek, Susan; Kelz, Rachel; Zhang, Paul; Czerniecki, Brian Journal: Journal of translational medicine Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. IMP1 3′ UTR shortening enhances metastatic burden in colorectal cancer. (8th November 2018) Authors: Andres, Sarah F; Williams, Kathy N; Plesset, Jacqueline B; Headd, Jeffrey J; Mizuno, Rei; Chatterji, Priya; Lento, Ashley A; Klein-Szanto, Andres J; Mick, Rosemarie; Hamilton, Kathryn E; Rustgi, Anil K Journal: Carcinogenesis Issue: Volume 40:Number 4(2019) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗